Aperam S.A. APEMY OTC

Aperam S.A. (APEMY) trades at a trailing P/E of 384.3, forward P/E of 23.3. Trailing earnings yield is 0.26%, forward earnings yield 4.29%. PEG 0.02 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

• VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 384.3); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.26%).
• Forward P/E 23.3 (down from trailing 384.3) — analysts expect earnings to grow, which would improve the valuation.
• PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
• Trailing Earnings Yield 0.26% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.29% as earnings recover.

Overall SharesGrow Score: 39/100 with 1/7 criteria passed.